Executive Summary
This digest covers 11 SEC filings related to US M&A and takeover activity, with a heavy concentration on SPAC lifecycle events (IPOs, unit separations, deadline extensions) and a smaller set of completed acquisitions.
The most material developments are the closing of three significant take-private deals: Apollo's acquisition of Emerald Holding and Questex, Ares Management's $1.7 billion buyout of Whitestone REIT, and Ligand Pharmaceuticals' $739 million acquisition of XOMA Royalty. These transactions signal continued private equity appetite for public companies in the B2B events, retail real estate, and biotech royalty sectors. The SPAC filings, while routine, reveal a sector still struggling to consummate deals, with one SPAC (Oak Woods) extending its deadline by 18 months, indicating persistent challenges in finding viable targets. The completed acquisitions of flyExclusive's aviation assets and Catalyst Bancorp's purchase of Lakeside Bancshares highlight ongoing consolidation in the private aviation and regional banking sectors. Overall, the period shows a bifurcated market: robust M&A activity for established operating companies, contrasted with a sluggish SPAC market where many vehicles are burning through extension periods without announced targets.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from July 13, 2026.
Investment Signals (11)
-
Apollo-managed funds completed the acquisition at $5.03/share, taking the company private. The deal creates a scaled B2B events platform with Questex, signaling PE conviction in the experiential events sector post-pandemic. [BULLISH for B2B events sector]
-
Ares Management completed its $1.7B all-cash acquisition at $19.00/share, adding 54 retail properties (4.8M sq ft). Ares' $644B AUM validates the value in high-growth market retail real estate. [BULLISH for well-located retail REITs]
- Ligand Pharmaceuticals ↓ (BULLISH)▲
Acquisition of XOMA Royalty for $739M is expected to be immediately accretive, adding $0.50 and $1.50 to adjusted EPS in 2026 and 2027, respectively. The deal more than doubles Ligand's royalty portfolio to 200+ assets.
-
Stockholders received $39.00/share cash plus a CVR for 75% of net litigation proceeds. The CVR provides a potential upside kicker, though its value is uncertain. [NEUTRAL/BULLISH for CVR holders]
-
Completed $41.1M cash acquisition of Lakeside Bancshares, adding $229.8M in loans and $277.6M in deposits. Combined assets reach $620M, but the all-cash deal may pressure near-term liquidity. [BULLISH for scale, BEARISH for liquidity]
- flyExclusive ↓ (BULLISH)▲
Acquired Jet.AI's aviation assets, including two HondaJets, a Citation CJ4, and $6.1M in SPCX shares. The deal strengthens fleet and customer base, with plans to monetize SPCX shares for growth.
- Bleichroeder Acquisition Corp. III ↓ (NEUTRAL)▲
Completed $345M IPO, placing proceeds in trust for a future business combination. No target identified yet, representing a blank-check with high optionality but no operational history.
- Oak Woods Acquisition Corp ↓ (BEARISH)▲
Shareholders approved extending the business combination deadline from 30 to 48 months, reflecting difficulty in finding a target. This is a red flag for SPAC viability.
- Bayview Acquisition Corp ↓ (BEARISH)▲
Deposited $50,000 for a second one-month extension (to Aug 19, 2026), with up to four more extensions possible. Repeated extensions without a deal signal challenges.
- DISCIPLINED GROWTH ACQUISITION Corp ↓ (NEUTRAL)▲
Unit separation effective July 17, 2026, allowing separate trading of shares and rights. A routine step, but may increase liquidity and volatility.
- Viking Acquisition Corp. II ↓ (NEUTRAL)▲
Unit separation effective July 20, 2026, for Class A shares and warrants. Similar to DGAC, a standard SPAC administrative event.
Risk Flags (10)
- Oak Woods Acquisition Corp / Deadline Extension↓ [HIGH RISK]▼
Shareholders approved extending the business combination deadline from 30 to 48 months, indicating the SPAC has been unable to find a suitable target within the original timeframe. This raises the risk of a forced liquidation or a low-quality deal.
- Bayview Acquisition Corp / Multiple Extensions↓ [MODERATE RISK]▼
This is the second of up to six permitted extensions, with only $50,000 deposited each time. The pattern suggests difficulty in securing a deal, increasing the likelihood of eventual liquidation or a distressed combination.
- Bleichroeder Acquisition Corp. III / No Target Identified↓ [MODERATE RISK]▼
As a newly IPO'd SPAC with no operations and no target identified, there is execution risk. The company must complete a business combination with a target valued at least 80% of trust assets, which may be challenging in the current environment.
- Catalyst Bancorp / All-Cash Acquisition↓ [MODERATE RISK]▼
The $41.1M all-cash deal for Lakeside Bancshares may pressure near-term liquidity. The combined loan-to-deposit ratio of 81.6% suggests moderate lending capacity, but cash depletion could limit future growth or dividend capacity.
- XOMA Royalty / CVR Uncertainty↓ [MODERATE RISK]▼
The Contingent Value Rights (CVRs) are tied to litigation proceeds, which are inherently uncertain. If the litigation fails, CVRs could be worthless, creating a potential overhang for former XOMA shareholders.
- Emerald Holding / Integration Risk↓ [MODERATE RISK]▼
The merger of Emerald and Questex creates a large B2B events platform, but full integration over the coming months carries operational and cultural risks. Any disruption could impact customer relationships and revenue.
-
Whitestone's common stock has ceased trading on public exchanges. Investors who did not tender shares are now forced to accept the $19.00 cash consideration, with no further upside. [LOW RISK for remaining holders]
- flyExclusive / SPCX Lock-Up Risk↓ [LOW RISK]▼
The acquired SPCX shares are subject to a staggered lock-up until December 2026. If flyExclusive needs to monetize these shares for growth, any delay or price decline could impact planned initiatives.
- Ligand Pharmaceuticals / Integration Risk↓ [MODERATE RISK]▼
The acquisition of XOMA Royalty adds over 100 assets, more than doubling the portfolio. Integration of these assets and realizing the expected $0.50-$1.50 EPS accretion carries execution risk.
-
The unit separation is a routine administrative step with no financial impact. However, it may signal that the SPAC is progressing toward a potential deal, which could be positive or negative depending on the target.
Opportunities (10)
- Ligand Pharmaceuticals / Accretive Acquisition↓ (OPPORTUNITY)◆
The XOMA Royalty acquisition is expected to add $0.50 and $1.50 to adjusted EPS in 2026 and 2027, respectively. With an updated 5-year outlook at Investor Day on Dec 8, 2026, this could be a catalyst for the stock.
- XOMA Royalty / CVR Upside↓ (OPPORTUNITY)◆
The CVR entitles holders to 75% of net proceeds from pending litigation. If the litigation is successful, CVRs could provide significant additional value beyond the $39.00/share cash consideration.
- Whitestone REIT / Ares Management Backing↓ (OPPORTUNITY)◆
Ares Management, with $644B AUM, acquired Whitestone at $19.00/share. The deal validates the value of Whitestone's 54 retail properties in high-growth markets. Investors could look for similar opportunities in the retail REIT space.
- Emerald Holding / Apollo Platform Creation↓ (OPPORTUNITY)◆
The combination of Emerald and Questex creates a scaled B2B events platform. Apollo's backing suggests a long-term value creation thesis, and the combined entity may pursue further acquisitions.
- flyExclusive / Fleet and Customer Expansion↓ (OPPORTUNITY)◆
The acquisition of Jet.AI's assets adds two HondaJets, a Citation CJ4, and future delivery positions for three Citation CJ3 aircraft. The company also became an authorized Starlink Aviation dealer, enhancing in-flight connectivity. This positions flyExclusive for growth in the private aviation market.
- Catalyst Bancorp / Scale and Market Position↓ (OPPORTUNITY)◆
The acquisition of Lakeside Bancshares increases Catalyst's total assets to $620M, with a stronger presence in Calcasieu Parish. The combined entity has a loan-to-deposit ratio of 81.6%, suggesting room for lending growth.
- Bleichroeder Acquisition Corp. III / Blank-Check Optionality↓ (SPECULATIVE OPPORTUNITY)◆
With $345M in trust and no target identified, this SPAC offers optionality. If management identifies a high-quality target, the stock could appreciate. However, this is highly speculative.
- Oak Woods Acquisition Corp / Extended Timeline↓ (SPECULATIVE OPPORTUNITY)◆
The extension to 48 months gives the SPAC more time to find a target. If a quality deal is announced, the stock could rally. However, the extension itself is a red flag.
- Bayview Acquisition Corp / Extension Pattern↓ (SPECULATIVE OPPORTUNITY)◆
The SPAC has up to four more extensions available. If a deal is announced before the final deadline, there could be upside. However, the repeated extensions suggest challenges.
- DISCIPLINED GROWTH ACQUISITION Corp / Unit Separation↓ (SPECULATIVE OPPORTUNITY)◆
The separation of shares and rights may increase liquidity and attract more investors. If the SPAC announces a deal, the rights could provide leveraged upside.
Sector Themes (6)
- Private Equity Appetite for Public Companies◆
Three take-private deals closed this period (Emerald Holding, Whitestone REIT, XOMA Royalty), signaling strong PE interest in acquiring undervalued public companies. Apollo and Ares are leading the charge, with a focus on B2B events and retail real estate.
- SPAC Market Struggles◆
Of the 5 SPAC filings, only 1 (Bleichroeder) is a new IPO. The others involve unit separations or deadline extensions, indicating a sluggish SPAC market. Oak Woods' 18-month extension and Bayview's multiple extensions highlight the difficulty in finding viable targets.
- Consolidation in Regional Banking◆
Catalyst Bancorp's acquisition of Lakeside Bancshares is a microcosm of the ongoing consolidation in the US regional banking sector. Smaller banks are merging to achieve scale, improve efficiency, and compete with larger institutions.
- Biotech Royalty Aggregation◆
Ligand's acquisition of XOMA Royalty more than doubles its royalty portfolio to 200+ assets. This trend of royalty aggregation is gaining traction as companies seek diversified, non-dilutive revenue streams from commercial-stage biotech products.
- B2B Events Sector Rebound◆
Apollo's creation of a combined Emerald/Questex platform signals confidence in the B2B events sector post-pandemic. The deal suggests that in-person events are recovering and that scale is key to capturing market share.
- Private Aviation Growth◆
flyExclusive's acquisition of Jet.AI's assets reflects ongoing consolidation in the private aviation industry. The addition of Starlink connectivity also highlights the trend toward enhanced in-flight technology and customer experience.
Watch List (8)
-
The company will provide an updated 5-year outlook on December 8, 2026. Watch for guidance on the XOMA Royalty integration and EPS accretion. [Date: Dec 8, 2026]
-
The company intends to monetize its $6.1M SPCX position in an orderly manner. Watch for any sales or announcements that could impact the stock. [Ongoing]
-
The SPAC has up to four more extensions. The next deadline is August 19, 2026. Watch for any deal announcements or further extensions. [Date: Aug 19, 2026]
-
With the extension to 48 months, the new deadline is approximately July 2028. Watch for any target announcements or shareholder redemptions. [Ongoing]
-
As a newly IPO'd SPAC with $345M in trust, watch for any announcements regarding a potential business combination target. [Ongoing]
-
The merger with Questex is expected to be fully integrated over the coming months. Watch for any updates on operational synergies or leadership changes. [Ongoing]
-
The stock has ceased trading. Watch for any final distributions or shareholder communications. [Completed]
-
With the acquisition closed, watch for the next quarterly earnings report to assess the impact on liquidity, loan growth, and profitability. [Next earnings: Q3 2026]
Filing Analyses
(11)
14-07-2026
Bleichroeder Acquisition Corp. III completed its initial public offering (IPO) of 34,500,000 units at $10.00 per unit, generating gross proceeds of $345,000,000. Simultaneously, it sold 8,500,000 private placement warrants for $8,500,000. The net proceeds of $345,000,000 have been placed in a trust account to fund a future business combination, but the company has not yet identified a target and has not commenced operations.
- · The company is a blank check company incorporated on April 1, 2026, and had not commenced operations as of July 8, 2026.
- · The company must complete a business combination with one or more target businesses having a fair market value of at least 80% of the trust account assets.
- · The company will only complete a business combination if it acquires 50% or more of the target's voting securities or a controlling interest.
- · Transaction costs totaled $21,364,856, including $6,000,000 cash underwriting fee, $14,700,000 deferred underwriting fee, and $664,856 other offering costs.
- · The company has an accumulated deficit of $12,975,528 and total shareholders' deficit of $12,974,378 as of July 8, 2026.
14-07-2026
Disciplined Growth Acquisition Corp. announced that holders of its units may elect to separately trade the Class A ordinary shares and rights included in the units, effective July 17, 2026. The units will continue to trade on the NYSE under the symbol DGACU, while the separated shares and rights will trade under DGAC and DGACR, respectively. This is a routine administrative step in the lifecycle of a SPAC and does not involve any financial results or a definitive business combination.
- · Separate trading of Class A ordinary shares and rights begins on July 17, 2026.
- · No fractional rights will be issued; only whole rights will trade.
- · Holders must contact Odyssey Transfer and Trust Company to separate units.
14-07-2026
Bayview Acquisition Corp deposited $50,000 into its trust account on July 14, 2026, to extend its deadline to complete an initial business combination by one month, from July 19, 2026 to August 19, 2026. This is the second of up to six permitted extensions. The filing reflects a routine procedural step to maintain the SPAC's timeline, with no indication of a definitive acquisition agreement or material financial change.
- · The extension is the second of up to six extensions permitted under the Second Amended and Restated Articles of Association.
- · The original deadline was July 19, 2026; the new deadline is August 19, 2026.
- · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
14-07-2026
Apollo-managed funds completed the acquisitions of Emerald Holding, Inc. and Questex, LLC, creating a scaled B2B experiential events and media platform. Emerald stockholders received $5.03 per share in cash, and the company's common stock has ceased trading on the NYSE. The combined company appointed a new executive leadership team, including Paul Miller as CEO and Vince DiMaggio as CFO, with full integration expected over the coming months.
- · The two companies will be fully integrated over the coming months.
- · Emerald's common stock has ceased trading and will no longer be listed on the New York Stock Exchange.
- · Advisors: Goldman Sachs & Co. LLC acted as exclusive financial advisor and Fried, Frank, Harris, Shriver & Jacobson LLP as legal counsel to Emerald; Gibson, Dunn & Crutcher LLP acted as legal counsel to Questex; RBC Capital Markets and RAN Advisory acted as lead financial advisors and PJT Partners as financial advisor to the Apollo Funds; Akin Gump Strauss Hauer & Feld LLP acted as legal counsel to the Apollo Funds.
- · Apollo had approximately $1.03 trillion of assets under management as of March 31, 2026.
14-07-2026
Ares Management Corporation completed its acquisition of Whitestone REIT for $19.00 per share in an all-cash transaction valued at approximately $1.7 billion. The deal adds 54 retail properties totaling about 4.8 million square feet across fast-growing U.S. markets. As a result, Whitestone will be delisted from public exchanges.
- · Whitestone will no longer be traded or listed on any public securities exchange.
- · Advisors included Citigroup Global Markets Inc. (lead financial advisor and financing provider to Ares), Morgan Stanley (financial advisor and financing provider), Kirkland & Ellis LLP (legal advisor to Ares), Dechert LLP (legal advisor to Citigroup and Morgan Stanley), BofA Securities (financial advisor and fairness opinion provider to Whitestone), Jones Lang LaSalle Securities (financial advisor to Whitestone), and Bass Berry & Sims (legal advisor to Whitestone).
- · As of March 31, 2026, Ares Management Corporation had over $644 billion of assets under management globally.
14-07-2026
Oak Woods Acquisition Corporation (OAKUR) held an extraordinary general meeting on July 8, 2026, where shareholders approved an amendment to the company's articles of association to extend the deadline to consummate a business combination from 30 months to 48 months from the closing of its IPO. The amendment also allows the company to elect up to two additional six-month extensions after the 36th month, provided the sponsor deposits $0.01 per extension. This extension provides the SPAC with additional time to find a target, but also reflects the company's inability to complete a deal within the original timeframe.
- · The amendment was approved as a special resolution at the EGM held on July 8, 2026.
- · The original deadline was 30 months from IPO closing; the new deadline is 48 months.
- · The sponsor must deposit $0.01 for each six-month extension, up to two times, as of March 28, 2027.
- · The amendment also provides redemption rights to public shareholders upon approval of any amendment affecting redemption obligations or pre-business combination activity.
14-07-2026
Viking Acquisition Corp. II announced that holders of its public units may elect to separately trade the underlying Class A ordinary shares and warrants starting July 20, 2026. The Class A ordinary shares will trade under the symbol "VAII" and the warrants under "VII WS" on the New York Stock Exchange. This is a routine structural event for a SPAC and does not involve any financial results or merger completion.
- · Separation of units into Class A ordinary shares and warrants becomes effective July 20, 2026.
- · Class A ordinary shares will trade under symbol "VAII" and warrants under "VII WS".
- · Holders must have their brokers contact Continental Stock Transfer & Trust Company to separate units.
14-07-2026
flyExclusive, Inc. completed the acquisition of Jet.AI's aviation assets, adding Jet Card members, two HondaJet aircraft, a Citation CJ4, future delivery positions for three Citation CJ3 aircraft, approximately $6.1 million in SPCX shares, and $5.3 million in cash. The transaction strengthens the company's fleet, customer base, and capital flexibility, supporting its strategy of disciplined growth and long-term shareholder value creation.
- · The acquired SPCX shares are held through a special purpose vehicle and are subject to a pre-IPO lock-up releasing on a staggered schedule until December 2026.
- · flyExclusive intends to monetize the SPCX position in an orderly manner to fund fleet growth and operating initiatives.
- · The company has become an authorized Starlink Aviation dealer, enabling next-generation in-flight connectivity.
- · flyExclusive continues to invest in proprietary technology, maintenance infrastructure, and operational capabilities.
14-07-2026
Ligand Pharmaceuticals has completed its acquisition of XOMA Royalty Corp for $39.00 per share in cash, plus one non-transferable Contingent Value Right (CVR) per share entitling holders to a portion of 75% of net proceeds from certain pending litigation. As a result, XOMA Royalty's common stock has been delisted from Nasdaq. The transaction was announced on April 27, 2026, and closed on July 14, 2026.
- · Leerink Partners served as lead financial advisor, H.C. Wainwright & Co. as financial advisor, and Gibson, Dunn & Crutcher LLP as legal advisor to XOMA Royalty.
- · XOMA Royalty is a biotechnology royalty aggregator that acquires future economics associated with pre-commercial and commercial therapeutic candidates.
14-07-2026
Ligand Pharmaceuticals completed its acquisition of XOMA Royalty for $39.00 per share in cash, totaling approximately $739 million in equity value. The deal adds over 100 biopharmaceutical royalty assets, including seven commercial products such as VABYSMO, OJEMDA, and MIPLYFFA, more than doubling Ligand's portfolio to over 200 assets. The transaction is expected to be immediately accretive, adding $0.50 and $1.50 per share to adjusted EPS in 2026 and 2027, respectively, though risks include integration challenges and uncertain CVR payouts.
- · XOMA Royalty stockholders received one non-transferable Contingent Value Right (CVR) per share entitling them to 75% of net proceeds from certain pending litigation.
- · XOMA Royalty common stock ceased trading on The Nasdaq Global Market upon completion.
- · Ligand will provide an updated 5-year outlook during Investor Day on December 8, 2026.
- · Advisors: Stifel (lead financial), Citi (financial), Paul Hastings (legal), Collected Strategies (strategic communications) for Ligand; Leerink Partners (lead financial), H.C. Wainwright & Co. (financial), Gibson Dunn (legal) for XOMA Royalty.
14-07-2026
Catalyst Bancorp, Inc. completed its acquisition of Lakeside Bancshares, Inc. for $41.1 million in cash ($19.58 per share), effective July 14, 2026. The deal increases Catalyst's total assets to approximately $620 million, with $390 million in loans and $478 million in deposits, and adds four branch locations in Calcasieu Parish. However, the combined entity's loan-to-deposit ratio (81.6%) suggests moderate lending capacity, and the acquisition was funded entirely in cash, which may pressure near-term liquidity.
- · The acquisition was announced in April 2026 and closed on July 14, 2026.
- · Lakeside Bank had $229.8 million in loans and $277.6 million in deposits as of March 31, 2026.
- · Catalyst Bancorp standalone assets were $288.5 million as of March 31, 2026.
- · The combined entity's loan-to-deposit ratio is approximately 81.6% ($390M loans / $478M deposits).
- · Branch and system conversion is planned for November 2026.
Get daily alerts with 11 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 11 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Merger & Acquisition SEC Filings
🇺🇸 More from United States
View all →July 14, 2026
US Pre-Market SEC Filings Roundup — July 14, 2026
US Pre-Market SEC Filings Roundup
July 13, 2026
US Pre-Market SEC Filings Roundup — July 13, 2026
US Pre-Market SEC Filings Roundup
July 13, 2026
US SEC Filings Daily Market Digest — July 13, 2026
US SEC Filings Daily Market Digest
July 13, 2026
S&P 500 Financials Sector SEC Filings — July 13, 2026
S&P 500 Financials Sector SEC Filings